CHRISTY WATTS: Open Payments
NPI 1215481221 · MCDONOUGH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 46 payments from 20 companies in 2025. Trend: 2023 $2,008 · 2024 $1,490 · 2025 $909
Food & beverage: $909
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $149 |
| PFIZER INC. | 8 | $143 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| SANOFI-AVENTIS U.S. LLC | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $45 |
| Boston Scientific Corporation | 1 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: NURTEC ODT, AIRSUPRA, Rybelsus, TZIELD, Ozempic, Wegovy, General - Erectile Dysfunction, Kerendia.
Industry payments across GA — which companies pay providers there.
